Sarepta Therapeutics (AB3A) Q4 2025 Earnings Report
DE:AB3A Q4 2025 EPS Results
- Actual EPS
- -EUR 3.52
- Consensus EPS
- -EUR 1.07
- Beat/Miss
- Missed by -EUR 2.45
- One Year Ago EPS
- EUR 1.34
DE:AB3A Q4 2025 Revenue Results
- Actual Revenue
- EUR 396.60M
- Expected Revenue
- EUR 330.94M
- Beat/Miss
- Beat by +EUR 65.66M
- YoY Revenue Growth
- -32.73%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/25/2026
- Time
- After Close
- Conference Call
- Wednesday, February 25, 2026
DE:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
DE:AB3A Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.07- | -1.61 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 0.19-0.04 | 1.69 | -102.65% (-1.74) | |
| May 06, 2026 | 2026 (Q1) | 0.872.58 | -4.12 | 162.61% (+6.70) | |
| Feb 25, 2026 | 2025 (Q4) | -1.07-3.52 | 1.34 | -362.00% (-4.86) | |
| Nov 03, 2025 | 2025 (Q3) | -0.65-1.61 | 0.3 | -629.41% (-1.92) | |
| Aug 06, 2025 | 2025 (Q2) | 0.741.69 | 0.06 | 2600.00% (+1.63) | |
| May 06, 2025 | 2025 (Q1) | -2.87-4.12 | 0.33 | -1343.24% (-4.45) | |
| Feb 26, 2025 | 2024 (Q4) | 1.691.34 | 0.42 | 219.15% (+0.92) | |
| Nov 06, 2024 | 2024 (Q3) | -0.070.30 | -0.41 | 173.91% (+0.72) | |
| Aug 07, 2024 | 2024 (Q2) | -0.120.06 | -0.24 | 125.93% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
